See also this year's filing and all EDGAR filings for this company.
PDF Report 0001398733_2023_Aquestive_Therapeutics_Inc.pdf
Logs
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001398733, Aquestive Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 39,888,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 1,435,000 |
2 | PropertyPlantAndEquipmentNet | 4,085,000 |
3 | remainder_Assets | 11,662,000 |
4 | LiabilitiesCurrent | 39,528,000 |
5 | LiabilitiesNoncurrent | 38,536,000 |
6 | remainder_Liabilities | 97,560,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 52,879,000 |
9 | ResearchAndDevelopmentExpense | 17,481,000 |
10 | remainder_Expenses | 31,829,000 |
11 | remainder_Revenues | 47,779,000 |
12 | remainder_NetIncome | 0 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 57,070,000 |
1 | Liabilities | 175,624,000 |
2 | Expenses | 102,189,000 |
3 | Revenues | 47,779,000 |
4 | StockholdersEquity | -118,554,000 |
5 | NetIncome | -54,410,000 |
6 | ComprehensiveNetIncome | -54,410,000 |
7 | BaseVar | 191,331,000 |
8 | EconomicCapitalRatio | -2.22 |